These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20971744)

  • 1. Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies.
    Bueno H; Betriu A; Heras M; Alonso JJ; Cequier A; García EJ; López-Sendón JL; Macaya C; Hernández-Antolín R;
    Eur Heart J; 2011 Jan; 32(1):51-60. PubMed ID: 20971744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial.
    Fernández-Avilés F; Alonso JJ; Peña G; Blanco J; Alonso-Briales J; López-Mesa J; Fernández-Vázquez F; Moreu J; Hernández RA; Castro-Beiras A; Gabriel R; Gibson CM; Sánchez PL;
    Eur Heart J; 2007 Apr; 28(8):949-60. PubMed ID: 17244641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between risk stratification at admission and treatment effects of early invasive management following fibrinolysis: insights from the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).
    Yan AT; Yan RT; Cantor WJ; Borgundvaag B; Cohen EA; Fitchett DH; Dzavik V; Ducas J; Tan M; Casanova A; Goodman SG;
    Eur Heart J; 2011 Aug; 32(16):1994-2002. PubMed ID: 21307037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: results from the prematurely terminated ADdressing the Value of facilitated ANgioplasty after Combination therapy or Eptifibatide monotherapy in acute Myocardial Infarction (ADVANCE MI) trial.
    ADVANCE MI Investigators
    Am Heart J; 2005 Jul; 150(1):116-22. PubMed ID: 16084157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolysis versus primary percutaneous intervention in ST-elevation myocardial infarction with long interhospital transfer distances.
    Beri A; Printz M; Hassan A; Babb JD
    Clin Cardiol; 2010 Mar; 33(3):162-7. PubMed ID: 20235202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.
    Denktas AE; Athar H; Henry TD; Larson DM; Simons M; Chan RS; Niles NW; Thiele H; Schuler G; Ahn C; Sdringola S; Anderson HV; McKay RG; Smalling RW
    JACC Cardiovasc Interv; 2008 Oct; 1(5):504-10. PubMed ID: 19463352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facilitated percutaneous coronary intervention (PCI) in patients with acute ST-elevation myocardial infarction: comparison of prehospital tirofiban versus fibrinolysis before direct PCI.
    Möckel M; Bocksch W; Strohm S; Kühnle Y; Vollert J; Nibbe L; Dietz R
    Int J Cardiol; 2005 Aug; 103(2):193-200. PubMed ID: 16080980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year survival in patients with ST-segment-elevation myocardial infarction according to modalities of reperfusion therapy: the French Registry on Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) 2005 Cohort.
    Danchin N; Puymirat E; Steg PG; Goldstein P; Schiele F; Belle L; Cottin Y; Fajadet J; Khalife K; Coste P; Ferrières J; Simon T;
    Circulation; 2014 Apr; 129(16):1629-36. PubMed ID: 24657993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of a pharmaco-invasive reperfusion strategy in rural ST-elevation myocardial infarction patients with expected delays due to long-distance transfers.
    Larson DM; Duval S; Sharkey SW; Garberich RF; Madison JD; Stokman PJ; Dirks TG; Westin RK; Harris JL; Henry TD
    Eur Heart J; 2012 May; 33(10):1232-40. PubMed ID: 22041553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).
    Thiele H; Eitel I; Meinberg C; Desch S; Leuschner A; Pfeiffer D; Hartmann A; Lotze U; Strauss W; Schuler G;
    JACC Cardiovasc Interv; 2011 Jun; 4(6):605-14. PubMed ID: 21700245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction.
    Armstrong PW; Gershlick AH; Goldstein P; Wilcox R; Danays T; Lambert Y; Sulimov V; Rosell Ortiz F; Ostojic M; Welsh RC; Carvalho AC; Nanas J; Arntz HR; Halvorsen S; Huber K; Grajek S; Fresco C; Bluhmki E; Regelin A; Vandenberghe K; Bogaerts K; Van de Werf F;
    N Engl J Med; 2013 Apr; 368(15):1379-87. PubMed ID: 23473396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study.
    Armstrong PW;
    Eur Heart J; 2006 Jul; 27(13):1530-8. PubMed ID: 16757491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Saltzman AJ; Stone GW; Claessen BE; Narula A; Leon-Reyes S; Weisz G; Brodie B; Witzenbichler B; Guagliumi G; Kornowski R; Dudek D; Metzger DC; Lansky AJ; Nikolsky E; Dangas GD; Mehran R
    JACC Cardiovasc Interv; 2011 Sep; 4(9):1011-9. PubMed ID: 21939942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy).
    Madsen MM; Busk M; Søndergaard HM; Bøttcher M; Mortensen LS; Andersen HR; Nielsen TT;
    Am J Cardiol; 2005 Dec; 96(11):1469-75. PubMed ID: 16310424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy of pharmacoinvasive management for ST-segment elevation myocardial infarction in smokers versus non-smokers (from the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction).
    Tan NS; Goodman SG; Cantor WJ; Tan MK; Yan RT; Bagnall AJ; Mehta SR; Fitchett D; Strauss BH; Yan AT;
    Am J Cardiol; 2014 Oct; 114(7):955-61. PubMed ID: 25118119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reperfusion before percutaneous coronary intervention in ST-elevation myocardial infarction patients is associated with lower N-terminal pro-brain natriuretic peptide levels during follow-up, irrespective of pre-treatment with full-dose fibrinolysis.
    Sinnaeve PR; Ezekowitz JA; Bogaerts K; Droogne W; Jarai R; Huber K; Granger CB; Desmet WJ; Armstrong PW; Van de Werf FJ;
    Eur Heart J; 2009 Sep; 30(18):2213-9. PubMed ID: 19586960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction.
    Thrane PG; Kristensen SD; Olesen KKW; Mortensen LS; Bøtker HE; Thuesen L; Hansen HS; Abildgaard U; Engstrøm T; Andersen HR; Maeng M
    Eur Heart J; 2020 Feb; 41(7):847-854. PubMed ID: 31504424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] trial).
    Nielsen PH; Terkelsen CJ; Nielsen TT; Thuesen L; Krusell LR; Thayssen P; Kelbaek H; Abildgaard U; Villadsen AB; Andersen HR; Maeng M;
    Am J Cardiol; 2011 Sep; 108(6):776-81. PubMed ID: 21757183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome up to one year following different reperfusion strategies in acute ST-segment elevation myocardial infarction: the Helsinki-Uusimaa Hospital District registry of ST-Elevation Acute Myocardial Infarction (HUS-STEMI).
    Viikilä J; Lilleberg J; Tierala I; Syvänne M; Kupari M; Salomaa V; Nieminen MS;
    Eur Heart J Acute Cardiovasc Care; 2013 Dec; 2(4):371-8. PubMed ID: 24338296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.